Published on in Vol 6, No 12 (2022): December
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/37144, first published
.
Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study
Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study
Journals
- Bagdia A, Joshi S, Koppiker C. Unofficial report by BreastGlobal team: Highlights and insights from the 18th St. Gallen Breast Cancer Conference 2023. Breast Global Journal 2023;1(2):98 View
- Alves J, Martins T, Esteves S, Dias C, Rodrigues P. Temporal and dynamic Bayesian networks for prognosis and diagnosis in clinical settings: A scoping review. Computers in Biology and Medicine 2025;198:111193 View
- Wuraola F, Ramruthan J, Reel E, Peck L, Thain E, Kerrigan C, Santiago A, Dare A, Covelli A, McCuaig J, Papadakos J, Rodin D, Jacobson M, Kingham P, Mango V, Alatise O, Cil T. Pilot Health Care Provider Education Program for BRCA1 / 2 Genetic Testing, Counseling, and Management in Nigeria. JCO Global Oncology 2026;(12) View